Sort
17,288 grants matching “multiple sclerosis”
Regulation of mTORC1 signaling by mROS and ATM
$49,214Brooke Elizabeth Christian · Yale University · F32 · FY2012 · NS
Improving Contraceptive Care for Pregnancy-Capable Veterans with Autoimmune Conditions
$48,974Zoe Hypatia Pleasure · University Of Washington · F31 · FY2024 · HD
Investigating the role of cannabinoid receptors in oligodendrocyte development
$48,974Tania G Miramontes · Oregon Health & Science University · F31 · FY2024 · NS
Cis-regulatory mechanisms governing RORgt expression in type 3 lymphocytes
$48,974Naren U Mehta · Duke University · F31 · FY2024 · AI
Investigating the role of protein quality control in osmotic stress adaptation
$48,974Kathy H Le · Stanford University · F31 · FY2024 · GM
Control of CNS Myelination by the E3 Ligase Component Fbxw7
$48,974Hannah Young Collins · Oregon Health & Science University · F31 · FY2024 · NS
Investigating the origin and role of the IgA+ B cell response to intracerebral hemorrhage
$48,974Sarah Ohashi · Yale University · F31 · FY2024 · NS
The Effects of Aging and Microglia Dysfunction on Remyelination
$48,974Genaro Olveda · Dartmouth College · F31 · FY2024 · NS
Microglia and S1PR1 Signaling in Multiple Sclerosis Associated Neuropathic Pain
$48,974Sydney Lamerand · University Of Pittsburgh At Pittsburgh · F31 · FY2024 · NS
ATG2 transfers lipids from ER exit site membranes to directly expand the growing autophagosome
$48,974Devin Fuller · Yale University · F31 · FY2024 · AG
Type I Interferon Mediated Restoration of Brain Endothelial Cell Function after Cerebral Infarction
$48,974Mary Claire Tuohy · Columbia University Health Sciences · F31 · FY2024 · NS
Inhibition of MIF nuclease-mediated parthanatos prevents neuron and oligodendrocyte death in the context of multiple sclerosis
$48,974Jackson Mace · Johns Hopkins University · F31 · FY2024 · NS
Investigating Fear of Falling in Multiple Sclerosis: An Interplay of Neural, Motor, Cognitive, and Psychological Factors
$48,970Taylor Takla · Wayne State University · F31 · FY2025 · HD
Regulation of anti- &pro-apoptotic functions of BAD
$48,928Buck Institute For Age Research · F32 · FY2004 · NS
Downstream Targets of Olig 2
$48,796Shwetal V Mehta · Dana-Farber Cancer Inst · F32 · FY2006 · NS
Analysis of node of Ranvier development in the zebrafish
$48,796Matthew G Voas · Stanford University · F32 · FY2006 · NS
Anatomical Distribution of Pathology in MS
$48,687Christopher Michael Holland · Boston University Medical Campus · F30 · FY2007 · NS
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
$48,649Weill Medical College Of Cornell Univ · F31 · FY2001 · NS
Qualification of Novel Immune Markers in Human Serum of Patients with MS
$48,628Michelle Sexton · University Of Washington · F32 · FY2009 · AT
AVONEX IN TREATING HIGH DEVELOPMENT OF MULTIPLE SCLEROSIS
$48,578Ohio State University · M01 · FY2000 · RR
EVALUATE EFFICACY OF AVONEX &SECONDARY MULTIPLE SCLEROSIS
$48,578Ohio State University · M01 · FY2000 · RR
SAFETY AND EFFICACY OF TWO DOSES OF BETASERON
$48,578Ohio State University · M01 · FY2000 · RR
PHASE 2 STUDY OF HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
$48,578Ohio State University · M01 · FY2000 · RR
Signal Transduction to p70 S6 Kinase 1
$48,496John Blenis · Harvard Medical School · R01 · FY2009 · GM
Chemokines in a novel murine model of DTH in the brain
$48,483Cleveland Clinic Lerner Col/Med-Cwru · R03 · FY2004 · TW